SCHEMBL5740769

SCHEMBL5740769

Ic1ncnc2c1ncn2C1CCCO1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 4/20 0.71
PI4K2B Q8TCG2 4/20 0.71
PI4K2A Q9BTU6 4/20 0.71
PI4KB Q9UBF8 4/20 0.71
MEN1 O00255 2/20 0.71
ALDH1A1 P00352 2/20 0.71
KMT2A Q03164 2/20 0.71
TP53 P04637 1/20 0.71
CYP2C9 P11712 1/20 0.71
NFKB1 P19838 1/20 0.71
MAPK1 P28482 1/20 0.71
HSD17B10 Q99714 1/20 0.71
APEX1 P27695 1/20 0.71
BLM P54132 1/20 0.71
ADCY1 Q08828 1/20 0.71
CYP2C19 P33261 1/20 0.66
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CYP1A2 P05177 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219612 0.96 CYP2C19 (0.68) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL14908001 0.84 PI4KA (0.72) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL14983401 0.83 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL896095 0.83 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL30352942 0.83 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL8712264 0.83 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL191944 0.83 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL1998927 0.83 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBMEN1
Methane SCHEMBL10551641 0.82 PI4KA (0.69) PI4KAPI4K2BPI4K2API4KBMEN1
SCHEMBL4572213 0.80 CYP2C19 (0.74) PI4KAPI4K2BPI4K2API4KBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2006-06-15 US disclosed
EP-1615926-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) 2006-01-18 EP disclosed
WO-2004094426-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof PRPF3, PURB, PRPF31 PI4KA 3154/4885PI4K2B 2539/4885PI4K2A 2489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.